news - International Biopharmaceutical Industry

Current Edition

news

Anti-rejection drug rapamycin shows promise in liver cancer

More than 20% of liver cancers have mutations in the β-catenin gene that may make them responsive to anti-rejection dr...

4 February 2019 news

Continue Reading →

news

Oxford Genetics signs licensing agreement with Aldevron to market lentiviral packaging plasmids

Oxford Genetics, a leading innovator of biopharmaceutical technologies, has signed a licensing agreement with world-class service organization, Aldevron to bring to m...

4 February 2019 news discovery and development | gene therapy

Continue Reading →

news

First Allogenic Cell Banks for CAR-T Cancer Therapy Products Created

TC BioPharm (TCB), developer of CAR-T immuno-oncology products, has completed its first allogenic Gamma Delta T (GDT) cell banks, it announced in a Jan. 22, 2019 pres...

4 February 2019 news

Continue Reading →

news

BioNTech buys MAB Discovery’s antibody research unit

German biotech BioNTech said it will buy all of MAB Discovery's assets, employees and proprietary methods for generation of monoclonal antibodies "Having exclusi...

4 February 2019 news

Continue Reading →

news

Pfizer receives positive CHMP opinion for Vizimpro® (dacomitinib) for the first-line treatment of adult patients with locally advanced or metastatic non-small cell lung cancer with EGFR-activating mutations

Pfizer today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommendi...

4 February 2019 news

Continue Reading →

news

Metrion Biosciences and LifeArc sign collaboration agreement for neuroscience-focused ion channel drug discovery

Novel small molecule programme aims to address major unmet medical need in neuroscience Collaboration focused on specific potassium ion channel target Cambridg...

4 February 2019 news

Continue Reading →

news

SGS Expands Testing Capabilities at Its Glasgow Facility

Geneva, Switzerland 29 January 2019: SGS, a leading bio/pharmaceutical analytical and bioanalytical contract solutions provider, today announced that it has invested ...

4 February 2019 news

Continue Reading →

news

Pherecydes Pharma reports successful patient treatment with bacteriophages

Phage therapy could offer an alternative treatment method in the fight against antimicrobial resistance Romainville, France, January 30, 2019 – Pherecydes Pharma, ...

4 February 2019 news

Continue Reading →

news

Hitachi Chemical Co. Ltd. to Acquire apceth Biopharma GmbH

MUNICH, Germany, January 31, 2019 / -- apceth Biopharma GmbH, a leading contract manufacturing organization in the field of cell and gene therapy, announces today tha...

4 February 2019 news

Continue Reading →

news

Abeona Therapeutics to Present New Supportive Data for Novel Gene Therapies at WORLDSymposium™

NEW YORK and CLEVELAND, Jan. 31, 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a leading clinical-stage biopharmaceutical company developing novel...

4 February 2019 news

Continue Reading →